Compounds
US10624898B2 · kind B2 · utility
0Cited by
17References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 2019 |
| Grant date | Apr 21, 2020 |
| Priority date | — |
| Expiry date | Jul 9, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.